Somerville, NJ, United States of America

Harry M Geyer

This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry M Geyer. Retrieved from https://idiyas.com/inventor/harry-m-geyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Somerville, NJ (US) (1981)
  • Flemington, NJ (US) (1981)

Company Filing History:


Years Active: 1981

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Harry M Geyer

Introduction

Harry M Geyer is a notable inventor based in Somerville, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of isoquinoline derivatives. With a total of 2 patents, Geyer has focused on creating compounds that have potential therapeutic applications.

Latest Patents

Geyer's latest patents include innovative compounds such as 3-Piperidino or piperazino-1-phenyl isoquinolines. These compounds are characterized by specific structural formulas where R1 can be piperidino or piperazino, and R2 is phenyl or its substituted variants. His work emphasizes the preparation of these isoquinolines and their use as antidepressants, showcasing their potential in the pharmaceutical industry.

Career Highlights

Harry M Geyer is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical sector. His research and inventions have contributed to advancements in medicinal chemistry, particularly in developing new antidepressant medications. Geyer's work is recognized for its potential impact on mental health treatment.

Collaborations

Geyer has collaborated with notable coworkers such as Wilhelm Bartmann and Elmar Konz. These partnerships have likely enhanced the research and development of his innovative compounds, fostering a collaborative environment for scientific advancement.

Conclusion

Harry M Geyer stands out as an influential inventor in the field of medicinal chemistry. His contributions, particularly in the development of isoquinoline derivatives, highlight his commitment to advancing therapeutic options for mental health. His work continues to inspire innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…